Estimation of seroprevalence of the pandemic H1N1 2009 influenza virus using a novel virus-free ELISA assay for the detection of specific antibodies

Viral Immunology

Volumn 24, Issue 3, 2011, Pages 221-226

  Mavrouli, Maria D ^a   Routsias, John G ^a   Maltezou, Helena C ^b   Spanakis, Nicholas ^a   Tsakris, Athanassios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b Hellenic Center for Disease Control and Prevention   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; SYNTHETIC PEPTIDE; VIRUS ANTIBODY; VIRUS HEMAGGLUTININ; VIRUS SIALIDASE;

2009 H1N1 INFLUENZA; 2009 INFLUENZA VIRUS A H1N1; AMINO ACID SEQUENCE; ANTIBODY DETECTION; ARTICLE; BLOOD SAMPLING; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; SEROPREVALENCE; VIRUS STRAIN;

ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CLINICAL LABORATORY TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREECE; HUMANS; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 79959310687     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2010.0137     Document Type: Article

References (25)

1. Allwinn R, Geiler J, Berger A, Cinatl J, and Doerr HW: Determination of serum antibodies against swine-origin influenza A virus H1N1/09 by immunofluorescence, haemagglutination inhibition, and by neutralization tests: how is the prevalence rate of protecting antibodies in humans? Med Microbiol Immunol 2010;199:117-121.
2. Alvarez MM, Lopez-Pacheco F, Aguilar-Yanez JM, et al.: Specific recognition of influenza A/H1N1/2009 antibodies in human serum: a simple virus-free ELISA method. PLoS One 2010;5:e10176.
3. Bouvier NM, and Palese P: The biology of influenza viruses. Vaccine 2008;26 Suppl 4:D49-D53.
4. Bragstad K, Nielsen LP, and Fomsgaard A: The evolution of human influenza A viruses from 1999 to 2006: a complete genome study. Virol J 2008;5:40.
5. Chan YJ, Lee CL, Hwang SJ, et al.: Seroprevalence of antibodies to pandemic (H1N1) 2009 influenza virus among hospital staff in a medical center in Taiwan. J Chin Med Assoc 2010;73:62-66.
6. Chang LY, Shih SR, Shao PL, Huang DT, and Huang LM: Novel swine-origin influenza virus A (H1N1): the first pandemic of the 21st century. J Formos Med Assoc 2009;108:526-532.
7. Efstathiou P, Tseroni M, Baka A, Manolidou Z, Karageorgou K, Syspa V, and Hatzakis A: Deaths and hospitalizations related to 2009 pandemic influenza A (H1N1) - Greece, May 2009-February 2010. MMWR Morb Mortal Wkly Rep 2010;59:682-686.
8. Ganzenmueller T, Kluba J, Hilfrich B, et al.: Comparison of the performance of direct fluorescent antibody staining, a point-of-care rapid antigen test and virus isolation with that of RT-PCR for the detection of novel 2009 influenza A (H1N1) virus in respiratory specimens. J Med Microbiol 2010;59:713-717.
9. General Directorate of Epidemiology, M. o. H., Mexico, P. A. H. Organization, W. H. Organization, P. H. A. o. Canada and C. U. States: Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:467-470.
10. Ginsberg M, Hopkins J, Maroufi A, et al.: Swine influenza A (H1N1) infection in two children - Southern California, March-April 2009. MMWR Morb Mortal Wkly Rep 2009;58:400-402.
11. Hancock K, Veguilla V, Lu X, et al.: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
12. Higgins AD, Shaw CJ, Johnson JG, et al.: A monoclonal antibody kit for identification of the novel 2009 H1N1 Influenza A virus. J Clin Microbiol 2010;48:2677-2682.
13. Itoh Y, Shinya K, Kiso M, et al.: In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025.
14. Klungthong C, Chinnawirotpisan P, Hussem K, et al.: The impact of primer and probe-template mismatches on the sensitivity of pandemic influenza A/H1N1/2009 virus detection by real-time RT-PCR. J Clin Virol 2010;48:91-95.
15. Lytras T, Theocharopoulos G, Tsiodras S, Mentis A, Panagiotopoulos T, and Bonovas S: Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill 2009;14.
16. McDonald NJ, Smith CB, and Cox NJ: Antigenic drift in the evolution of H1N1 influenza A viruses resulting from deletion of a single amino acid in the haemagglutinin gene. J Gen Virol 2007;88:3209-3213. (Pubitemid 350201829)
17. Miller E, Hoschler K, Hardelid P, Stanford E, Andrews N, and Zambon M: Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010;375:1100-1108.
18. Nakajima N, Hata S, Sato Y, et al.: The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examination. Jpn J Infect Dis 2010;63:67-71.
19. Newman AP, Reisdorf E, Beinemann J, et al.: Human case of swine influenza A (H1N1) triple reassortant virus infection, Wisconsin. Emerg Infect Dis 2008;14:1470-1472.
20. Panagiotopoulos T, Bonovas S, Danis K, et al.: Cluster of new influenza A(H1N1) cases in travellers returning from Scotland to Greece - community transmission within the European Union? Euro Surveill 2009;14.
21. Rachiotis G, Mouchtouri VA, Kremastinou J, Gourgoulianis K, and Hadjichristodoulou C: Low acceptance of vaccination against the 2009 pandemic influenza A(H1N1) among healthcare workers in Greece. Euro Surveill 2010;15.
22. Ross T, Zimmer S, Burke D, et al.: Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza 2010;RRN1148.
23. Tsiodras S, Sypsa V, and Hatzakis A: The vaccination campaign against 2009 pandemic influenza A(H1N1) and its continued importance in view of the uncertainty surrounding the risk associated with the pandemic. Euro Surveill 2010;15.
24. Wu W, Kang X, Bai Z, et al.: Detection of pandemic influenza A/H1N1/2009 virus by real-time reverse transcription polymerase chain reaction. J Virol Methods 2010;165:294-296.
25. Yongfeng H, Fan Y, Jie D, Jian Y, Ting Z, Lilian S, and Jin Q: Direct pathogen detection from swab samples using a new high-throughput sequencing technology. Clin Microbiol Infect 2010.